1,25-Vitamin D-mediated hypercalcaemia in the setting of immune therapy-related sarcoid-like reaction
We presented a case of a 72-year-old male with severe hypercalcaemia of 3.84 mmol/L following the second cycle of immunotherapy with ipilimumab and nivolumab in the setting of metastatic melanoma with known bone metastases. Further investigations demonstrated hilar lymphadenopathy, which was not pre...
Saved in:
Main Authors: | R K Dharmaputra, N Sheriff, S Ravichandran |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2025-02-01
|
Series: | Endocrinology, Diabetes & Metabolism Case Reports |
Subjects: | |
Online Access: | https://edm.bioscientifica.com/view/journals/edm/2025/1/EDM-24-0116.xml |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is hypercalcaemia immediately life-threatening? A prospective study
by: David Trewick, et al.
Published: (2025-01-01) -
Ursodeoxycholic acid for the treatment of hepatic sarcoid: A pre-post pilot study
by: Ethan Weinberg, et al.
Published: (2024-07-01) -
In vitro evaluation of the immunomodulatory and antibacterial activities of calcitriol (1,25-dihydroxy-vitamin D3) as a potential application for aerobic vaginitis treatment - preliminary study results
by: Anna Tomusiak-Plebanek, et al.
Published: (2025-01-01) -
Prevalence and outcomes associated with hypocalcaemia and hypercalcaemia among pre-dialysis chronic kidney disease patients with mineral and bone disorder
by: Mei Hui Amanda Yong, et al.
Published: (2024-08-01) -
Hypovitaminosis D in patients with oral leukoplakia: insights from a cross-sectional study
by: Andrea Maturana-Ramirez, et al.
Published: (2025-02-01)